Adrenal Tumors and Paragangliomas

OR34-1

Evaluation of a Multi-Gene Panel Test for Inherited Paragangliomas and Pheochromocytomas.  Is It Time to Re-Assess Guidelines for Genetic Testing?
Carolyn Horton, Michelle Jackson, Amal Yussuf, Rachel McFarland, Holly LaDuca and Kory Jasperson

OR34-2

Superiority of 68ga-Dotatate PET/CT Compared to Other Radiopharmaceuticals in Metastatic Pheochromocytomas/Paragangliomas and Paragangliomas of the Head and Neck
Ingo Janssen, Clara C Chen, Corina M Millo, Peter Herscovitch, Alexander Ling, Nicholas J. Patronas, David Taieb, Tito Fojo, Electron Kebebew and Karel Pacak

OR34-3

New Innovative Rapid Assay of Plasma Aldosteorne Concentration and Active Renin Concentration Are Effective for Diagnosing Primary Aldosteronism
Yoshikiyo Ono, Ryo Morimoto, Yuta Tezuka, Kei Omata, Masahiro Nezu, Yasuhiro Igarashi, Yoshitsugu Iwakura, Masataka Kudo, Kazumasa Seiji, Kei Takase, Yuto Yamazaki, Yasuhiro Nakamura, Hironobu Sasano, Sadayoshi Ito and Fumitoshi Satoh

OR34-4

Liquid Chromatography High Resolution Mass Spectrometry Steroid Profiling in Patients with Indeterminate Masses
Irina Bancos, Jolaine Hines, Wiebke Arlt, William F. Young Jr. and Ravinder J. Singh

OR34-5

Re-Setting the Abnormal Circadian Cortisol Rhythm in Patients with Adrenal Incidentalomas and Subclinical Hypercortisolism
Miguel Debono, Robert F Harrison, Rita Chadarevian, Carole Gueroult, Jean-Louis Abitbol and John Newell-Price

OR34-6

Non-Functional Adrenal Adenomas and Incident Cardiometabolic Outcomes
Diana M Lopez, Miguel Angel Luque Fernandez, Gail K. Adler, Alexander Turchin and Anand Vaidya